Inventor · disambiguated record
Rex A. Parker
Also filed as: PARKER REX A · PARKER REX ARNOLD · PARKER Rex
17 granted patents·7 pending applications·379 citations·filing 1990–2023
95Inventor score
Top patents by PatentIndex Score
24 records- 0198US7572618B2Polynucleotides encoding novel PCSK9 variantsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 11, 2009·93 cites·22 claims
- 0297US8420098B2Fibronectin based scaffold domain proteins that bind to PCSK9CAMPHAUSEN RAY·Filed 2011·Granted Apr 16, 2013·86 cites·8 claims
- 0396US7846706B2PCSK9 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Dec 7, 2010·22 cites·14 claims
- 0494US8354264B2Polynucleotides encoding novel PCSK9 variantsBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 15, 2013·11 cites·10 claims
- 0592US9856309B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 2, 2018·10 cites·16 claims
- 0691US10947297B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 16, 2021·5 cites·19 claims
- 0791US5217992ATocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disordersBRISTOL MYERS SQUIBB CO·Filed 1990·Granted Jun 8, 1993·45 cites·6 claims
- 0890US10442851B2Serum albumin-binding fibronectin type III domainsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 15, 2019·5 cites·12 claims
- 0990US9234027B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 12, 2016·10 cites·22 claims
- 1090US8105804B2Polynucleotides encoding novel PCSK9 variantsMINTIER GABRIEL A·Filed 2010·Granted Jan 31, 2012·12 cites·16 claims
- 1186US11203630B2Serum albumin-binding fibronectin type III domainsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 21, 2021·2 cites·9 claims
- 1286US2024239870A1Fibronectin based scaffold domain proteins that bind pcsk9BRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1381US7358254B2Method for treating atherosclerosis employing an aP2 inhibitor and combinationBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 15, 2008·14 cites·2 claims
- 1480US5348974ATocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disordersBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Sep 20, 1994·37 cites·6 claims
- 1576US11858979B2Fibronectin based scaffold domain proteins that bind PCSK9BRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jan 2, 2024·0 cites·10 claims
- 1676US6984645B2Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding proteinBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jan 10, 2006·8 cites·14 claims
- 1775US2020010564A1Antibodies that bind novel pcsk9 variantsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 1871US2014161808A1Antibodies that bind novel pcsk9 variantsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1968US2013108612A1Polynucleotides encoding novel pcsk9 variantsBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 2063US2009076033A1Method for treating atherosclerosis employing an aP2 inhibitor and combinationROBL JEFFREY A·Filed 2008·Application pending·0 cites
- 2163US2016347860A1Antibodies that bind novel pcsk9 variantsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 2255US7390824B1Method for treating diabetes employing an aP2 inhibitor and combinationBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jun 24, 2008·19 cites·8 claims
- 2335US2002035064A1Method for treating atherosclerosis employing an aP2 inhibitor and combinationFiled 2001·Application pending·0 cites
- 2430US5488068AAminobiphenyl-4-ol anti-atherosclerotic compounds and methodBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jan 30, 1996·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Rex A. Parker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →